Document Detail

Early airway pressure release ventilation prevents ARDS-a novel preventive approach to lung injury.
MedLine Citation:
PMID:  23247119     Owner:  NLM     Status:  MEDLINE    
Acute respiratory distress syndrome (ARDS) afflicts 200,000 patients annually with a mortality rate of 30% to 60% despite wide use of low tidal volume (LTV) ventilation, the present standard of care. High-permeability alveolar edema and instability occur early in the development of ARDS, before clinical signs of lung injury, and represent potential targets for therapy. We hypothesize that early application of a protective ventilation strategy (airway pressure release ventilation [APRV]) will stabilize alveoli and reduce alveolar edema, preventing the development of ARDS. Yorkshire pigs (30-40 kg) were anesthetized and subjected to two-hit injury: (a) intestinal ischemia-reperfusion, (b) peritoneal sepsis, or sham surgery. Following surgery, pigs were randomized into APRV (n = 4), according to current published guidelines for APRV; LTV ventilation (n = 3), using the current published ARDS Network guidelines (6 mL/kg); or sham (n = 5). The clinical care of all pigs was administered per the Surviving Sepsis Campaign guidelines. Animals were killed, and necropsy performed at 48 h. Arterial blood gases were measured to assess for the development of clinical lung injury. Lung tissue epithelial cadherin (E-cadherin) was measured to assess alveolar permeability. Bronchoalveolar lavage fluid (BALF) surfactant protein A was measured to assess alveolar stability. Lung edema content and histopathology were analyzed at 48 h. Airway pressure release ventilation pigs did not develop ARDS. In contrast, pigs in the LTV ventilation met ARDS criteria (PaO2/FIO2 ratio) (APRV: baseline = 471 ± 16; 48 h = 392 ± 8; vs. LTV ventilation: baseline = 551 ± 28; 48 h = 138 ± 88; P < 0.001). Airway pressure release ventilation preserved alveolar epithelial integrity demonstrated by higher levels of E-cadherin in lung tissue as compared with LTV ventilation (P < 0.05). Surfactant protein A levels were higher in BALF from the APRV group, suggesting APRV preserved alveolar stability. Quantitative histologic scoring showed improvements in all stigmata of ARDS in the APRV group versus the LTV ventilation (P < 0.05). Airway pressure release ventilation had significantly lower lung edema (wet-dry weight) than LTV ventilation (P < 0.05). Protective ventilation with APRV immediately following injury prevents development of ARDS. Reduction in lung edema, preservation of lung E-cadherin, and surfactant protein A abundance in BALF suggest that APRV attenuates lung permeability, edema, and surfactant degradation. Protective ventilation could change the clinical paradigm from supportive care for ARDS with LTV ventilation to preventing development of ARDS with APRV.
Shreyas Roy; Nader Habashi; Benjamin Sadowitz; Penny Andrews; Lin Ge; Guirong Wang; Preyas Roy; Auyon Ghosh; Michael Kuhn; Joshua Satalin; Louis A Gatto; Xin Lin; David A Dean; Yoram Vodovotz; Gary Nieman
Related Documents :
6870029 - Cardiovascular and shivering responses in hypothermic and rewarmed young calves.
16250719 - Prediction of resting cardiovascular functioning in youth with family histories of esse...
24032449 - Calculating osmotic pressure of xylitol solutions from molality according to unifac mod...
24762189 - Hyperoxia affects the regional pulmonary ventilation/perfusion ratio: an electrical imp...
23653299 - Reversal of pulmonary hypertension after diaphragm pacing in an adult patient with cong...
19910579 - Monoamine oxidase a-mediated enhanced catabolism of norepinephrine contributes to adver...
14728069 - Ace inhibition with moexipril: a review of potential effects beyond blood pressure cont...
23861619 - Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular ...
10624199 - An investigation of the benefits of aquacel hydrofibre wound dressing.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Shock (Augusta, Ga.)     Volume:  39     ISSN:  1540-0514     ISO Abbreviation:  Shock     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-18     Completed Date:  2013-06-03     Revised Date:  2014-01-10    
Medline Journal Info:
Nlm Unique ID:  9421564     Medline TA:  Shock     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28-38     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Lung Injury / pathology,  physiopathology,  prevention & control*
Bronchoalveolar Lavage Fluid / chemistry
Cadherins / metabolism
Carbon Dioxide / blood
Continuous Positive Airway Pressure / methods*
Hemodynamics / physiology
Lung Compliance / physiology
Multiple Organ Failure / prevention & control
Oxygen / blood
Partial Pressure
Pulmonary Edema / prevention & control
Pulmonary Surfactant-Associated Protein A / metabolism
Respiratory Distress Syndrome, Adult / pathology,  physiopathology,  prevention & control*
Severity of Illness Index
Sus scrofa
Tidal Volume / physiology
Time Factors
Water-Electrolyte Balance / physiology
Grant Support
Reg. No./Substance:
0/Cadherins; 0/Pulmonary Surfactant-Associated Protein A; 142M471B3J/Carbon Dioxide; S88TT14065/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Silencing of fas, fas-associated via death domain, or caspase 3 differentially affects lung inflamma...
Next Document:  Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gu...